Fox Chase Cancer Center Appoints Renowned Immunotherapy Expert Dr. Lorenzo Galluzzi as Associate Professor
核心洞察
Dr. Lorenzo Galluzzi, a highly cited researcher in cancer (搜索) immunotherapy (搜索), joins Fox Chase Cancer Center as a tenured Associate Professor in the Cancer Signaling and Microenvironment Research Program.
Prior to this appointment, Dr. Galluzzi led research at Weill Cornell Medical College focusing on cancer (搜索) cell stress responses and immune activation during various cancer therapies.
With over 500 published scientific articles and multiple editorial roles, Dr. Galluzzi brings extensive expertise in tumor immunology and cellular pathology to strengthen Fox Chase's research initiatives.
Fox Chase Cancer Center has announced the appointment of Dr. Lorenzo Galluzzi as Associate Professor with tenure in the Cancer (搜索) Signaling and Microenvironment Research Program, marking a significant addition to their research faculty.
Research Focus and Expertise
Dr. Galluzzi's research primarily investigates the complex relationship between cancer (搜索) cell stress responses and immune system activation during cancer treatments. At his previous position as Assistant Professor at Weill Cornell Medical College, his laboratory concentrated on understanding how immunotherapy (搜索), chemotherapy (搜索), and radiation therapy (搜索) trigger immune responses targeting tumors.
"We are enormously excited to welcome Dr. Galluzzi to the Fox Chase and Temple family and look forward to working with him to further strengthen an already robust research program," said Dr. Edna "Eti" Cukierman, Co-Leader of the Cancer (搜索) Signaling and Microenvironment Research Program and Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research.
Academic Leadership and International Recognition
Dr. Galluzzi maintains several prestigious academic appointments, including an Assistant Professor Adjunct position at Yale School of Medicine's Department of Dermatology. He also serves as faculty at multiple Italian institutions, including the University of Ferrara, University of Padova, and University of Rome's graduate programs.
His leadership extends to prominent roles in international research organizations, serving as the Associate Director of the European Academy for Tumor Immunology and as a founding member of the European Research Institute for Integrated Cellular Pathology.
Scientific Impact and Editorial Responsibilities
With over 500 peer-reviewed publications, Dr. Galluzzi has consistently been recognized as a highly cited researcher worldwide from 2006 through 2023. His scientific influence is further demonstrated through his editorial leadership roles, serving as Editor-in-Chief for several prestigious journals including OncoImmunology and Molecular and Cellular Oncology.
Educational Background and Professional Affiliations
Dr. Galluzzi completed his doctoral studies at Paris-Sud University in 2008, followed by postdoctoral training at the Gustave Roussy Comprehensive Cancer (搜索) Center in Paris. He maintains active memberships in numerous professional organizations, including the Society for Immunotherapy (搜索) of Cancer and the American Association for Cancer Research, reflecting his commitment to advancing cancer research and treatment strategies.